ABVC BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 221.1%.

Top 25 shareholders own 29.98% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.48%	Eugene Jiang	998,760	US$1.1m	20%	no data
8.28%	Shuling Jiang	872,552	US$933.6k	11.3%	no data
4.13%	Tsung-Shann Jiang	434,616	US$465.0k	2,090%	no data
1.69%	Chase Investment Counsel Corporation	178,377	US$190.9k	0%	0.07%
0.69%	Uttam Patil	72,428	US$77.5k	0%	no data
0.55%	Yoshinobu Odaira	57,758	US$61.8k	253%	no data
0.49%	Leeds Chow	52,007	US$55.6k	19,000%	no data
0.46%	LionGene Corporation	48,761	US$52.2k	-4.37%	no data
0.46%	Hsin-Hui Miao	48,072	US$51.4k	0%	no data
0.45%	The Vanguard Group, Inc.	46,947	US$50.2k	72.3%	no data
0.4%	Tsang Ming Jiang	41,994	US$44.9k	6,820%	no data
0.4%	Yen-Hsin Chou	41,956	US$44.9k	7,270%	no data
0.4%	Yu-Min Chung	41,943	US$44.9k	7,440%	no data
0.4%	Norimi Sakamoto	41,854	US$44.8k	8,860%	no data
0.4%	Chang-Jen Jiang	41,847	US$44.8k	9,000%	no data
0.4%	Che-Wei Hsu	41,723	US$44.6k	12,300%	no data
0.34%	Renaissance Technologies LLC	36,100	US$38.6k	0%	no data
0.26%	Citadel Advisors LLC	27,158	US$29.1k	74.2%	no data
0.18%	Geode Capital Management, LLC	19,480	US$20.8k	0%	no data
0.092%	BioFirst Corporation	9,675	US$10.4k	323%	no data
0.016%	Rgene Corporation	1,687	US$1.8k	1,750%	no data
0.0096%	Genepro Investment Company	1,012	US$1.1k	14.4%	no data
0.0055%	Tower Research Capital LLC	578	US$618.8	-80.6%	no data
0.0022%	BioLite Inc.	227	US$242.3	-0.44%	no data
0.00095%	Spotlight Asset Group, Inc.	100	US$107.1	0%	no data